Am­gen, look­ing for a path in­to red-hot 'mol­e­c­u­lar glues,' inks a deal with Plex­i­um for 2 pro­grams, po­ten­tial­ly more

As phar­ma con­tin­ues to seek new break­throughs across drug modal­i­ties, few ar­eas have gar­nered more in­ter­est than pro­tein degra­da­tion. And Am­gen is tak­ing a fly­er …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER